glp-1 drugs eli lilly FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - LLY Stock Surges on Breakthrough

1922 Hypoglycemia was not found to be increased with GLP-1RA when compared to placebo

Weight loss has been associated with improvement in HS symptoms [30,31,32]

Studies have suggested that in addition to diabetes, GLP-1R agonists may also have a beneficial effect on many other diseases such as cardiovascular disease, central nervous disorder, and tumors ( 4.2 Cardiovascular disease The latest research has found that GLP-1R is widely expressed in the cardiovascular system and is involved in intracellular metabolism and signal transduction

Image adapted from: Saraiva, FK and Sposito, A

The multidistrict litigation (MDL) was created after dozens of people filed lawsuits after they allegedly developed severe gastrointestinal complications from taking Mounjaro or another GLP-1 product